Transcept (TSPT) Announces Common Offering

Transcept Pharmaceuticals, Inc. (Nasdaq: TSPT), is offering to sell shares of its common stock in an underwritten public offering. Transcept expects to grant the underwriters a 30-day option to purchase additional shares of common stock offered in the public offering to cover over-allotments, if any. All of the shares in the offering are to be sold by Transcept. The offering is subject to market conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.

Leerink Swann LLC and Lazard Capital Markets LLC are acting as joint book-running managers of the offering.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Columbus Circle Capital Corp. III closes $230M IPO on Nasdaq
• Faraday Future registers up to 62M shares for resale
• Niagen Bioscience files to sell up to $50M in common stock